Results 281 to 290 of about 355,535 (359)

[Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].

, 1988
H Gülker, H Heuer, B Frenking, Wilhelm Haverkamp, Gerhard Hindricks, Bev Bozek, C Bremkes, Asche Kd, D Witthöft   +8 more
openalex  

Some of the next articles are maybe not open access.

Related searches:

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

[How to develop an anti-arrhythmia agent in 1990. The industrialist's viewpoint].

, 1991
E Roland
openalex  

[Adenosine as an anti-arrhythmia agent].

Deutsche medizinische Wochenschrift (1946), 1996
M J, Scheininger, M, Wehling
openaire   +1 more source

An update on larynx cancer

Ca-A Cancer Journal for Clinicians, 2017
Kristin A Higgins, Nabil F Saba
exaly  

[Evaluation of anti-arrhythmia agents in the animal model].

, 1992
Lehmann Hd
openalex  

[USE OF ANTI-ARRHYTHMIA AGENTS].

[Sogo rinsho] Clinic all-round, 1996
N, KIMURA, T, WADA
openaire   +1 more source

Nanooncology: The future of cancer diagnosis and therapy

Ca-A Cancer Journal for Clinicians, 2013
Sanjiv S Gambhir
exaly  

[Pharmacological properties and therapeutic effectiveness of ajmalin--a new anti-arrhythmia agent. (Review of the literature)].

, 1965
Gendenshteĭn Ei, Davidovskiĭ Nm
openalex  

[Molecular modeling of anti-arrhythmia agents in class Ia and Ib--model conceptions of different binding receptors].

, 1989
Stephan Marrer
openalex